IL20 and neoplasm: Anti-IL–20 and anti-IL-20R1 mAbs are highly stained on tumor cells, but anti-IL-20R2 and anti-IL-22R1 mAbs are not (Fig 1A, 1B, 1C and 1D, arrows) on the representative carcinoma tissues.